The present work delineates pairwise interactions underlying the nanomolar affinity of ␣-conotoxin MI (CTx MI) for the ␣-␦ site of the muscle acetylcholine receptor (AChR). We mutated all non-cysteine residues in CTx MI, expressed the ␣ 2 ␦ 2 pentameric form of the AChR in 293 human embryonic kidney cells, and measured binding of the mutant toxins by competition against the initial rate of 125 I-␣-bungarotoxin binding. The CTx MI mutations P6G, A7V, G9S, and Y12T all decrease affinity for ␣ 2 ␦ 2 pentamers by 10,000-fold. Side chains at these four positions localize to a restricted region of the known three-dimensional structure of CTx MI. Mutations of the AChR reveal major contributions to CTx MI affinity by Tyr-198 in the ␣ subunit and by the selectivity determinants Ser-36, Tyr-113, and Ile-178 in the ␦ subunit. By using double mutant cycles analysis, we find that Tyr-12 of CTx MI interacts strongly with all three selectivity determinants in the ␦ subunit and that ␦Ser-36 and ␦Ile-178 are interdependent in stabilizing Tyr-12. We find additional strong interactions between Gly-9 and Pro-6 in CTx MI and selectivity determinants in the ␦ subunit, and between Ala-7 and Pro-6 and Tyr-198 in the ␣ subunit. The overall results reveal the orientation of CTx MI when bound to the ␣-␦ interface and show that primarily hydrophobic interactions stabilize the complex.Recent studies have used protein toxins to probe active sites of ligand-and voltage-gated ion channels (1-6). By identifying multiple pairwise interactions, these studies define dimensions of the active site according to the known structure of the toxin. The studies also establish the underlying basis for molecular recognition in high affinity protein complexes. Here we probe the muscle AChR 1 with the peptide toxin ␣-conotoxin MI and use double mutant cycles analysis to identify pairs of residues that confer the nanomolar affinity of the complex.Mutagenesis and site-directed labeling studies establish that the ligand binding sites of the muscle AChR are formed at interfaces between ␣ 1 and either ␦, ⑀, or ␥ subunits (7,8). Residues on the ␣ 1 face of the binding site are found in three well separated regions of the primary sequence, termed loops A, B, and C. Using the numbering system for the mouse ␣ 1 subunit, key residues in these loops include Tyr-93 in loop A, in loop C. Similarly, residues on the non-␣ face of the binding site are found in four well separated regions of the primary sequence, termed loops I through IV. Using the numbering system for the mouse ␦ subunit, key residues in these loops include Ser-36 in loop I, Trp-57 in loop II, Tyr-113 in loop III, and Ile-178 in loop IV. The observation that these seven loops converge to form a localized binding site has led to a multi-loop model of the major extracellular domain of the AChR (8).␣-Conotoxins are small, disulfide-rich peptides that competitively inhibit muscle and neuronal nicotinic AChRs (9). All ␣-conotoxins have a conformationally constrained two-loop structure formed by two disulfide ...